Literature DB >> 2445049

A study of intracytoplasmic inclusions in myeloma cells from two patients with multiple myeloma.

K Tsuchikawa1, H Yokomichi, I Satoh, C Suzuki, Y Watanabe, G Tajima.   

Abstract

Two cases of multiple myeloma which showed inclusions within the cytoplasma of myeloma cells were reported. One contained crystalline inclusions which were not stained by May-Grünwald and Giemsa, and the other contained Auer rod-like spindle shaped inclusions which were stained by May-Grünwald and Giemsa and PAS. Both cases were stained intensively by acid phosphatase but they were not stained by Congo red or by thioflavine-T. Moreover, they reacted only with anti-kappa sera in the immunofluorescent study and showed the same structure on electron microscopic observation. Although they showed different staining behaviors according to their compositions, they were considered to be essentially the same. It appears that light chains produced in excess are concentrated and form inclusions through the addition of sugar or digestion by lysosomal enzymes.

Entities:  

Mesh:

Year:  1987        PMID: 2445049     DOI: 10.1620/tjem.153.11

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  Aggregates, crystals, gels, and amyloids: intracellular and extracellular phenotypes at the crossroads of immunoglobulin physicochemical property and cell physiology.

Authors:  Haruki Hasegawa
Journal:  Int J Cell Biol       Date:  2013-03-05

2.  Clinical significance of granule-containing myeloma cells in patients with newly diagnosed multiple myeloma.

Authors:  Kazuhito Suzuki; Shingo Yano; Kaichi Nishiwaki; Koji Sano; Takaki Shimada; Yuichi Yahagi; Yoji Ogasawara; Katsuki Sugiyama; Shinobu Takahara; Takeshi Saito; Kinuyo Kasama; Jiro Minami; Hiroki Yokoyama; Yutaro Kamiyama; Atsushi Katsube; Hidekazu Masuoka; Mitsuji Katori; Tomohito Machishima; Aya Ouchi; Nobuaki Dobashi; Ken Kaito; Noriko Usui; Keisuke Aiba
Journal:  Cancer Med       Date:  2016-10-13       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.